- This event has passed.
Primary Healthcare Sharing Session
July 18, 2023 @ 2:00 pm - 5:00 pm
Dear HKAPI Members,
We are delighted to invite you to our Primary Healthcare Sharing Session, organized by the HKAPI Primary Healthcare Task Force. The event is scheduled to take place on 18th July 2023 at 14:00 and will be conducted face-to-face.
This session aims to provide a platform for industry members to share insights and updates on the latest policies and developments in primary healthcare. The topics that will be covered include policy overview and updates on the Government’s Primary Healthcare Blueprint, Chronic Disease Co-Care Scheme to be rolled out within 2023, the Strategic Purchasing Office and Community Drug Formulary, as well as the Primary Healthcare Commission and its future development.
We believe that this event will provide a valuable opportunity for you to network with other industry professionals and to stay informed on the latest trends and developments in primary healthcare. We encourage you to RSVP as soon as possible to secure your attendance.
Details of the event are as follows:
Date: 18 July 2023 (Tue)
Time: 14:00- 17:00 (3 hours)
Target audience: Senior Executives in Market Access, Commercial Leads, Mid-Level, Front-line Managers, Market Access Colleagues, Commercial Leads, Mid-Level Front-line Managers
Language: Cantonese, slides in English
Format: Presentation, Group Discussion, Interactive Polling and Q&A
Venue: The Hong Kong Management Association, 14/F, Fairmont House, 8 Cotton Tree Drive, Central, HONG KONG
RSVP: Please contact the Ms Catherine Chau of the HKAPI Office (email: [email protected]/ Tel: 2528 3061)
Agenda:
I. Update on latest development of Primary Healthcare Blueprint
- Overview of Primary Healthcare Blueprint
- Role and governance of Strategic Purchasing Office and Primary Healthcare Office
- Key Learnings about Primary Healthcare Office and Taskforce recommendations
II. Group Discussion:
- District Health Centre’s role in improving patient journey.
- Business opportunity and challenge in private sector
III. Update of Strategic Purchasing Office
- Community Drug Formulary
- Subsidy and patient co-payment
